October 18, 2021
Breakthrough T1D Official Statement on Vertex Pharmaceutical’s Clinical Trial for VX-880 Results Announcement
October 12, 2021
vTv Therapeutics Announces Positive Results from Mechanistic Study Indicating No Increased Risk of Ketoacidosis with TTP399 during Acute Insulin Withdrawal in Patients with Type 1 Diabetes
September 30, 2021
Breakthrough T1D Awards New Grant to Explore Cognitive Behavioral Therapy to Reduce Diabetes Distress
September 15, 2021
Breakthrough T1D Announces the Addition of Shia Learns About Insulin book into the Bag of Hope
September 14, 2021
Raise Awards Honors Nonprofits Shaping the Future of Fundraising
September 9, 2021
National Diabetes Coalition Provides Support for The Diabetes Community In The Aftermath Of Hurricane Ida
August 18, 2021
Breakthrough T1D Announces the Appointment of Dr. Shereef Elnahal to the Breakthrough T1D Research Committee
August 12, 2021
Game Over, T1D! Breakthrough T1D Fundraiser Aims to Raise $75,000 for Type 1 Diabetes Research
July 29, 2021
Breakthrough T1D Statement on FDA Approval of First Interchangeable Biosimilar Insulin
July 23, 2021
Breakthrough T1D Mourns the Loss of Professor David Dunger
